Cargando…

Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus

Childhood-onset lymphocytic infundibuloneurohypophysitis (LINH) due to infiltration of autoimmune lymphocyte in the neurohypophysis is rarely reported. Its definitive diagnosis requires a pituitary biopsy, which is an invasive procedure. Recently, anti-rabphilin-3A antibody has been reported as a po...

Descripción completa

Detalles Bibliográficos
Autores principales: Kume, Yohei, Sakuma, Hiroko, Sekine, Hitomi, Sumikoshi, Makoto, Sugimura, Yoshihisa, Hosoya, Mitsuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783119/
https://www.ncbi.nlm.nih.gov/pubmed/33446956
http://dx.doi.org/10.1297/cpe.30.65
_version_ 1783632045435518976
author Kume, Yohei
Sakuma, Hiroko
Sekine, Hitomi
Sumikoshi, Makoto
Sugimura, Yoshihisa
Hosoya, Mitsuaki
author_facet Kume, Yohei
Sakuma, Hiroko
Sekine, Hitomi
Sumikoshi, Makoto
Sugimura, Yoshihisa
Hosoya, Mitsuaki
author_sort Kume, Yohei
collection PubMed
description Childhood-onset lymphocytic infundibuloneurohypophysitis (LINH) due to infiltration of autoimmune lymphocyte in the neurohypophysis is rarely reported. Its definitive diagnosis requires a pituitary biopsy, which is an invasive procedure. Recently, anti-rabphilin-3A antibody has been reported as a potential diagnostic marker for LINH in adults; however, only a few cases have been reported in children. Here, we present a case of childhood-onset LINH in a 10-yr-old boy identified as anti-rabphilin-3A antibody positive during chronic phase, 9 yr post-onset of central diabetes insipidus (CDI). T1-weighted magnetic resonance imaging (MRI) revealed pituitary stalk thickening and absence of posterior pituitary bright signal spot, and the hormonal responses of the adenohypophysis to GHRH, TRH, CRH, and LHRH revealed no abnormalities during the first admission. MRI at 5 mo post-onset indicated reduced stalk swelling; however, replacement treatment with intranasal desmopressin was continued to counter unimproved CDI. Additionally, GH replacement therapy was also initiated to counter its deficiency. Pituitary re-enlargement was not observed in the subsequent routine MRI, and no increase was observed in the levels of tumor markers during follow-up, which was considered clinically consistent with LINH. Our case study suggests that anti-rabphilin-3A antibody may be considered as a useful diagnostic marker for LINH in children.
format Online
Article
Text
id pubmed-7783119
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Society for Pediatric Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-77831192021-01-13 Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus Kume, Yohei Sakuma, Hiroko Sekine, Hitomi Sumikoshi, Makoto Sugimura, Yoshihisa Hosoya, Mitsuaki Clin Pediatr Endocrinol Case Report Childhood-onset lymphocytic infundibuloneurohypophysitis (LINH) due to infiltration of autoimmune lymphocyte in the neurohypophysis is rarely reported. Its definitive diagnosis requires a pituitary biopsy, which is an invasive procedure. Recently, anti-rabphilin-3A antibody has been reported as a potential diagnostic marker for LINH in adults; however, only a few cases have been reported in children. Here, we present a case of childhood-onset LINH in a 10-yr-old boy identified as anti-rabphilin-3A antibody positive during chronic phase, 9 yr post-onset of central diabetes insipidus (CDI). T1-weighted magnetic resonance imaging (MRI) revealed pituitary stalk thickening and absence of posterior pituitary bright signal spot, and the hormonal responses of the adenohypophysis to GHRH, TRH, CRH, and LHRH revealed no abnormalities during the first admission. MRI at 5 mo post-onset indicated reduced stalk swelling; however, replacement treatment with intranasal desmopressin was continued to counter unimproved CDI. Additionally, GH replacement therapy was also initiated to counter its deficiency. Pituitary re-enlargement was not observed in the subsequent routine MRI, and no increase was observed in the levels of tumor markers during follow-up, which was considered clinically consistent with LINH. Our case study suggests that anti-rabphilin-3A antibody may be considered as a useful diagnostic marker for LINH in children. The Japanese Society for Pediatric Endocrinology 2021-01-05 2021 /pmc/articles/PMC7783119/ /pubmed/33446956 http://dx.doi.org/10.1297/cpe.30.65 Text en 2021©The Japanese Society for Pediatric Endocrinology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Kume, Yohei
Sakuma, Hiroko
Sekine, Hitomi
Sumikoshi, Makoto
Sugimura, Yoshihisa
Hosoya, Mitsuaki
Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus
title Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus
title_full Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus
title_fullStr Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus
title_full_unstemmed Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus
title_short Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus
title_sort lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3a antibodies nine years post-onset of central diabetes insipidus
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783119/
https://www.ncbi.nlm.nih.gov/pubmed/33446956
http://dx.doi.org/10.1297/cpe.30.65
work_keys_str_mv AT kumeyohei lymphocyticinfundibuloneurohypophysitiswithpositiveantirabphilin3aantibodiesnineyearspostonsetofcentraldiabetesinsipidus
AT sakumahiroko lymphocyticinfundibuloneurohypophysitiswithpositiveantirabphilin3aantibodiesnineyearspostonsetofcentraldiabetesinsipidus
AT sekinehitomi lymphocyticinfundibuloneurohypophysitiswithpositiveantirabphilin3aantibodiesnineyearspostonsetofcentraldiabetesinsipidus
AT sumikoshimakoto lymphocyticinfundibuloneurohypophysitiswithpositiveantirabphilin3aantibodiesnineyearspostonsetofcentraldiabetesinsipidus
AT sugimurayoshihisa lymphocyticinfundibuloneurohypophysitiswithpositiveantirabphilin3aantibodiesnineyearspostonsetofcentraldiabetesinsipidus
AT hosoyamitsuaki lymphocyticinfundibuloneurohypophysitiswithpositiveantirabphilin3aantibodiesnineyearspostonsetofcentraldiabetesinsipidus